Halozyme Therapeutics
HALO
$44.71
Share price
-1.50%
Change (1 day)
32.00%
Change (1 year)
Categories
Halozyme Therapeutics (HALO) Fails to deliver data
Key failure to deliver metrics for Halozyme Therapeutics:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $0.29 M
- Last year FTD volume: $11.14 M
Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013
Volume in USD (price x number of shares), data since 2013Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $1.93 M | -92.42% |
| 2023 | $25.5 M | -15.59% |
| 2022 | $30.2 M | 38.39% |
| 2021 | $21.82 M | -6.23% |
| 2020 | $23.27 M | -44.23% |
| 2019 | $41.74 M | 591.9% |
| 2018 | $6.03 M | -64.48% |
| 2017 | $16.98 M | -5.65% |
| 2016 | $17.99 M | -13.05% |
| 2015 | $20.7 M | -7.81% |
| 2014 | $22.45 M | 140.61% |
| 2013 | $9.33 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.13 B | $0.59 B | 🇺🇸 USA |
 Pfizer PFE | $10.32 M | $0.31 B | 🇺🇸 USA |
 Eli Lilly LLY | $56.64 M | $0.12 B | 🇺🇸 USA |
 Sanofi SNY | $21.22 M | $52.23 M | 🇫🇷 France |
 Baxter BAX | $10.57 M | $49.06 M | 🇺🇸 USA |
 MannKind Corp MNKD | $11.43 M | $14.68 M | 🇺🇸 USA |